Content » Vol 93, Issue 3

Clinical Report

Analysis of High-dose Intravenous Immunoglobulin Therapy in 16 Patients with Refractory Autoimmune Blistering Skin Disease: High Efficacy and No Serious Adverse Events

Supplementary content
Table SI
Table SII
Table SIII
Table SIV
Licenses
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.